What do systematic reviews say?

Pre‐dilution vs post‐dilution (as defined by study investigators)

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pre‐dilution vs post‐dilution (as defined by study investigators)

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pre‐dilution vs post‐dilution (as defined by study investigators)

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pre‐dilution vs post‐dilution (as defined by study investigators)

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 47 participants
  Low

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 693 participants
  Low

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 729 participants
  Moderate

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 39 participants
  Very low

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 93 participants
  Very low

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 753 participants
  Low

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 753 participants
  Low

Pre‐emptive medication vs prophylaxis

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 753 participants
  Low

Prebiotic vs placebo or no treatment

• Synbiotics, prebiotics and probiotics for people with chronic kidney disease 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 44 participants
  Very low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 288 participants
  Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 217 participants
  Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 185 participants
  Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 176 participants
  Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 36 participants
  Very low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

• Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 114 participants
  Low

Hypothermic machine perfusion vs static cold storage (SCS)

Hypothermic machine perfusion leads to lower DGF: pre‐2008 studies compared with static cold storage (high certainty).

• Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation 2019 · Cochrane Headline outcomes only
  RR 0.78 [0.61, 0.99]
  9 studies · 783 participants
  High

Interventions for increasing immunosuppressant medication adherence vs usual care

It is very uncertain whether interventions for increasing immunosuppressant medication adherence changes proportion of immunosuppressant trough concentration levels at target compared with standard care (very low certainty).

• Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients 2022 · Cochrane Headline outcomes only
  RR 0.98 [0.68, 1.4]
  4 studies · 348 participants
  Very low